RxDoctor Payments Data

Patrick Dickerson, MD

Orthopaedic Surgery · Rogers, ARNPI 1467718619

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (47.6%), education and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Arthrex at 54.3% of the total. Reporting peaked in 2019 at $30,231 and has fallen 99.6% since, to $133 in 2025. Among orthopaedic surgery clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$46,620in general payments, 2019–2025

Across 146 payments — averaging $319.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$25K
  • Zimmer Biomet$7K
  • Midsouth Orthopedics Inc.$5K
  • Smith+Nephew$5K
  • DJO, LLC$2K
  • Stryker$2K
  • plus $296 from 4 others

What the payments were for

  • Grants$22,18848%
  • Travel & lodging$8,33918%
  • Food & beverage$5,01311%
  • Education$11,08124%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex42$25,312
Zimmer Biomet49$7,344
Midsouth Orthopedics Inc.27$5,357
Smith+Nephew7$4,606
DJO, LLC2$2,188
Stryker13$1,517
Johnson & Johnson2$131
Peerless Surgical Inc.1$94
Medical Device Business Services, Inc.2$54
Pacira Pharmaceuticals Incorporated1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$46,620 in reported general payments places this provider in the 90th percentile of 168 orthopaedic surgery providers in Arkansas.

See all orthopaedic surgery providers in Arkansas

Medicare billing

Part B allowed, 2024
$195,015
Medicare patients
346
Services billed
2,019

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban17$11,600
Celecoxib63$1,639
Oxycodone Hcl202$1,523
Ondansetron OdtOndansetron118$1,298
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen24$295
Mupirocin23$135
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$123
Meloxicam41$88
Tramadol Hcl20$73
Cephalexin15$47

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$131$11,60017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 168 orthopaedic surgery providers in Arkansas.

Other orthopaedic surgery in Rogers

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →